Company intelligence / Profile preview

Sabaa International

Cairo, Cairo, Egypt

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Sabaa International is an Egyptian pharmaceutical company primarily engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The company focuses on several therapeutic areas including cardiovascular, gastrointestinal, anti-infectives, and neurology. It operates a significant manufacturing facility in Egypt and is publicly traded on the Egyptian Exchange.

Therapeutic areas: ImmunologyEndocrinologyCardiovascularNeurologyInfectious DiseasesGastroenterology
Modalities: Small molecule
Industry: Biotech

Partnerships

Various regional distributors in the MENA region

Beyond the preview

Go deeper on Sabaa International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sabaa International.

Explore the full profile